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a span of 14 days. Five out of 23 cases including the first laboratory-confirmed case were treated at Baby Memorial Hospital (BMH), Kozhikode.
Objective
The objective of the study was to describe the clinical characteristics and epidemiology of the outbreak of NiV infection in Kerala in May 2018.
methods
The retrospective study was conducted by a collaborative team of physicians and epidemiologists from the Research Cell of Indian Medical Association (IMA) and the BMH and the Medical College Hospital (MCH) Kozhikode, the two hospitals where most of the cases were being admitted. The clinical and exposure history and the data on outbreak response were gathered from hospital medical records and by interviewing patient relatives and health-care workers using questionnaires. We visited residential places and health-care institutions where the spread occurred. Thirty respondents were interviewed and two target group discussions involving health-care workers and patient relatives were held. The study period was from May 20 to June 5.
Case definition
We followed the guidelines of the National Centre for Disease Control for case definitions. [6] A probable case is defined as a suspect case who resided in the same village as the confirmed case or who came in direct contact with a confirmed case in a hospital setting during the outbreak period and developed symptoms of respiratory distress and/or encephalitis and died before diagnostic specimen could be collected. A confirmed case is defined as a suspect case whose serum or urine or respiratory secretions or cerebrospinal fluid (CSF) tested positive for NiV RNA by Real Time polymerase chain reaction (RT-PCR) or by isolation of NiV from any of these fluids.
ResUlts
We identified 23 patients including 5 probable cases 21 of whom (91.3%) died. Eighteen were confirmed cases and tested positive for NiV by RT-PCR. It was found that all cases, except one, contracted the virus in three public hospitals. The index case was assumed to be infected from fruit bats. Out of 22 cases (excluding index case), 19 had exposure to the index case at various locations. Three cases contracted the infection from some of the primary cases. The median age was 45 years. Sixty-five percent of them were males.
Clinical features
The most common symptom was fever (100%) followed by altered sensorium (84.2%). Tachycardia, hypertension, segmental myoclonus and segmental sweating were seen in 63.1%, 36.8%, 15.7% and 15.7% respectively. Shortness of breath was seen in 14 out of 19 patients (73.6%). The median incubation period was 9.5 days (range, 4-14 days), and the mean duration of illness was 6.4 days. A comparative account of clinical features of patients admitted to the two hospitals, i.e., BMH and MCH are shown in Table 1 .
First laboratory-confirmed case
A 28-year-old male with fever, vomiting, and altered sensorium was referred to BMH from Sub-district hospital (SDH), Perambra, in the early hours of May 17, 2018. He was diaphoretic, restless and confused on arrival at the emergency room (ER). He had hypertension (180/100 mmHg), tachycardia (180/min), and tachypnea (36/min). Nervous system examination revealed hypotonia of all four limbs, diminished deep tendon reflexes and limb myoclonus. Chest examination showed bilateral diffuse fine crackles. He was admitted to the multidisciplinary intensive care unit. Blood tests like complete blood counts, hepatic, renal, and coagulation parameters were normal, except mild thrombocytopenia (140,000 cells/mm 3 ). Arterial blood gases (ABGs) was normal. Computed tomography (CT) brain revealed cerebral edema. He was electively intubated, and intermittent positive pressure ventilation was instituted. His initial bedside echocardiogram (ECHO) was normal. Intravenous (IV) mannitol was administered, and lumbar puncture was done. A CSF study showed elevated protein and sugar levels. Cell count was normal. He was started on empirical treatment with IV acyclovir and ceftriaxone for probable central nervous system infection. His father and aunt who had similar signs and symptoms were brought to 
Index case
On retrospective investigation, it was found that a 26-year-old brother of the first confirmed case had similar symptoms since May 2, 2018, and was admitted to SDH, Perambra, on May 3, 2018. He later died at MCH on May 5, 2018. This is considered as the index case. His clinical features included fever, altered sensorium, headache, myalgia, cough, shortness of breath, and vomiting which were consistent with encephalitis, sepsis, and acute respiratory distress syndrome (ARDS). Nonspecific presentation besides limited time to investigate the case led to the ignorance of an impending epidemic.
In search of the source of outbreak, the Nipah link with Pteropus bats was confirmed and established by the NIV and Indian Council of Medical Research. About 19.2% (10/52) of the bats collected from the outbreak area tested positive for NiV by RT-PCR. [7] The timing of the outbreak coincided with the breeding season of bats, a known zoonotic reservoir. The index case, who was an animal lover, might have come in contact with NiV-infected bat pup, or might have consumed bat-bitten fruits which were explained as the likely modes of transmission. The possible date of infection to the index case could be between April 11-27, 2018, based on the documented incubation period of the disease (4-21 days).
Further transmission
Among the 23 cases identified, 19 were primary cases who contracted the infection from the index case while he was admitted to SDH, Perambra, and MCH between May 4-5, 2018. The wards, ER, and radiology room were the places of exposure. Of the 3 secondary cases, 2 contracted the disease at MCH and 1 at SDH, Balussery, where the primary cases were treated. The cases comprised of immediate family members, patients and their bystanders, and caregivers. Three patients on May 17, 2018, and one patient on May 19, 2018, had succumbed with features of encephalitis and ARDS. All these patients had come into close contact with the index case either at SDH, Perambra, or at MCH. They were identified as probable Table 2 summarizes the list of patients source of infection, nature of exposure, and outcome. Figure 1 shows the incidence of NiV cases on each day from 1 st May to 31 st May. Peak incidence was noted between 11 th to 23 rd May which corresponds to the incubation period of NiV. Figure 2 shows the epidemic curve with incidence and mortality rates. Figure 3 shows number of patients exposed to index case each location.
Overcrowding, inadequate ventilation, and improper infection control practices in the wards, ERs, and the corridors of some public hospitals contributed to the rapid spread of infection. The hospital staff was not using hand gloves, face mask, and other personal protective equipment, and they were not following hand hygiene precautions. This led to an easy transmission of infection to patients, bystanders, and caregivers in these hospitals.
Outbreak response
After Table 3 .
Radiological abnormalities
Abnormal chest X-ray was seen in 5 out of 18 patients (27.7%). Of these, 3 patients had bilateral fluffy shadows and 1 had patchy opacities in the right lower zone suggestive of ARDS [ Figure 4 ]. CT brain was done in 5 patients, of which 2 had normal findings, 2 had diffuse brain edema and early hydrocephalus and 1 had diffused cerebral atrophy with chronic infarcts. Magnetic resonance imaging brain of 1 patient showed nonspecific white matter hyperintensities on T2-weighted fluid-attenuated inversion recovery sequence [ Figure 5 ].
Treatment
Patients with respiratory distress received both noninvasive ventilation and intermittent positive pressure ventilation. A majority received IV antibiotics to prevent secondary bacterial infection. Patients with seizures received antiepileptics. Raised intracranial tension and brain edema were managed with mannitol and dexamethasone. Those who developed hypertensive crisis received antihypertensives. Patients in septic shock received vasopressors and crystalloids. Out of 19 patients, 8 (42.1%) received ribavirin. IV acyclovir was initially given to 3 patients, and later, it was changed to ribavirin 1200 mg/day (in 6 divided doses). The 2 patients who survived received ribavirin for 14 days, and it was started in the early stage of illness.
discUssion
This retrospective study is aimed at providing an insight into the clinical manifestations, laboratory features, and epidemiology of the first NiV outbreak experienced in Kerala. The case fatality rate (91.3%) was very high in the outbreak.
It was found that only the index case was infected in the community from fruit bats. Rest of the cases were due to transmission of the virus in 3 public hospitals.
There are important differences between the clinical and epidemiological descriptions of NiV infection in Kerala and those of the Malaysian outbreak. Unlike in Malaysian outbreak where direct contact with infected pigs was identified as the mode of transmission to humans, here, fruit bats are suspected to be the source of infection, and ingestion of bat-bitten fruits is propounded to be the mode of transmission to the index case. [8] All other cases resulted from human-to-human spread by close contact. In Bangladesh epidemics between 2001 and 2007, NiV was contracted from an infected domestic cow, consumption of date palm sap contaminated by bat secretions, and human-to-human transmission. [9] In a study by Goh et al., 91 out of 94 (97%) patients had fever as compared to Kerala where all of them presented with fever. [10] Headache was present in 36.8% (7/19), whereas it was noted in 74.9% of the patients in Malaysian outbreak. [11] In Siliguri, fever was present in all and headache and myalgia in 5%. [4] Altered sensorium was present in 16 84.2% (16/19) in comparison to 71.6% in Malaysia [11] and 97% in Siliguri outbreak. [4] Segmental myoclonus and segmental sweating were present in 15.7% cases (3/19), whereas it was noted in 49.3% and 26.2% of the patients, respectively, in Malaysia. [11] Hypertension was present in 36.8% (7/19 ) and tachycardia in 63.1% (12/19) towards the end of illness. Many patients developed hypertension before death in Siliguri outbreak. [4] Hypertension and tachycardia were noted in 43.3% and 42.3% of Malaysian patients, respectively. [11] These features are because of brainstem dysfunction during later stages of the illness. The incidence of seizures was 10.5% (2/19) , in contrast to Malaysian outbreak where it was 23.2%. [11] In Siliguri, it was not possible to differentiate between involuntary movements and seizures. [4] Hyporeflexia was present in 26.3% (5/19 ) and limb weakness in 10.5% (2/19) patients. These features were also present in seriously ill patients of Malaysian and Siliguri outbreaks. [4, 11] Only 5.2% (one patient) had meningism, whereas signs of meningeal irritation were not noted in Siliguri, [4] and 19.1% of the cases had meningism in Malaysia. [11] One patient had cerebellar ataxia, and this was a unique finding because it was not recorded in Malaysia and Siliguri. [4, 11] Cranial nerve involvement was seen in 15.7% of the patients (2 patients had bilateral ptosis and 1 had lateral rectus palsy). In Malaysia, pinpoint pupils were noted in a majority of the patients, whereas in Siliguri, all patients had dilated pupils. [4, 11] In Singapore, 2 out of 11 patients presented with pneumonia without encephalitis. [12] Kerala had both respiratory and neurological manifestations of NiV, unlike Malaysian where only neurological disease was seen. [11] About 73.6% (14/19) of the patients had ARDS (characterized by fall in oxygen saturation, bilateral crackles on respiratory examination, and diffuse pulmonary infiltrates on chest X-ray requiring ventilation support). In Siliguri outbreak, respiratory involvement was seen in 51% of the cases. [4] In Bangladesh epidemics between 2001 and 2004, respiratory distress was noted in 69% of the cases. [13] genomic similarity was observed among the NiV strains that caused Bangladesh, Siliguri, and Kerala outbreaks. Nucleotide sequences of Siliguri strain showed 99% similarity to Bangladesh strain. [4] Kerala strain was 97% identical to Bangladesh strain. [14] Variations in genomic structure could be the reason for the absence of respiratory system involvement in Malaysian outbreak, while it was a chief manifestation in Bangladesh, Siliguri, and Kerala outbreaks. High rates of human-to-human transmission in Bangladesh, Siliguri, and Kerala outbreaks might also be because of the genomic similarity. Respiratory symptoms and diarrhea could have contributed to high transmission rates among humans in Kerala. [15] Another unique feature was myocardial dysfunction in 7 patients, which was not reported in previous outbreaks. The mortality rate was 91.3% (21/23) which was much higher than the Malaysian (40%) and Siliguri (68%) outbreaks. One of the major confounding factors might be poor infection control precautions at SDH, Perambra, and MCH, Kozhikode. The two patients, who survived, received ribavirin in the early stages. This might be a coincidence or a treatment response which can be established only by further studies on ribavirin.
conclUsion
Although the first confirmation of diagnosis was made in one of the primary cases and a swift response from various stakeholders curtailed the spread of the infection in less than a month, rapid initial spread of infection through public hospitals uncovered the miserable state of health-care system in implementing infection control measures. The transmission seemed to have stopped in health facilities which had stricter infection control protocols. Hence, adoption of stringent institution-based infection control practices in all hospitals is a need of the hour to avert epidemics. Considering the fact that NiV is conquering new territories each year, the role of ecological factors such as deforestation and urbanization needs to be studied. "One health" approach that includes animal surveillance enhances early detection of zoonotic infections. Taking high case fatality and socioeconomic burden caused by NiV into account, there is a need for appropriate treatment strategies, vaccines, and diagnostics for fatal diseases such as NiV infection.
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